Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Plasma S100A8/A9 heterodimer is an early prognostic marker of acute kidney injury associated with cardiac surgery.

Nikolakopoulou Z, Hector LR, Creagh-Brown BC, Evans TW, Quinlan GJ, Burke-Gaffney A.

Biomark Med. 2019 Feb;13(3):205-218. doi: 10.2217/bmm-2018-0238. Epub 2019 Feb 27.

2.

Drug-Coated Balloon-Only Percutaneous Coronary Intervention for the Treatment of De Novo Coronary Artery Disease: A Systematic Review.

Mohiaddin H, Wong TDFK, Burke-Gaffney A, Bogle RG.

Cardiol Ther. 2018 Dec;7(2):127-149. doi: 10.1007/s40119-018-0121-2. Epub 2018 Oct 27. Review.

3.

The value of mobile tablet computers (iPads) in the undergraduate medical curriculum.

Patel S, Burke-Gaffney A.

Adv Med Educ Pract. 2018 Aug 10;9:567-570. doi: 10.2147/AMEP.S163623. eCollection 2018.

4.

Drug-eluting balloons with provisional bail-out or adjunctive stenting in de novo coronary artery lesions-a systematic review and meta-analysis.

Patel S, Svermova T, Burke-Gaffney A, Bogle RG.

Cardiovasc Diagn Ther. 2018 Apr;8(2):121-136. doi: 10.21037/cdt.2017.10.09.

5.

Clinical solutions: not always what they seem?

Burke-Gaffney A, Creagh-Brown BC.

Crit Care. 2015 May 7;19:213. doi: 10.1186/s13054-015-0870-4. No abstract available.

6.

Raised plasma Robo4 and cardiac surgery-associated acute kidney injury.

Burke-Gaffney A, Svermova T, Mumby S, Finney SJ, Evans TW.

PLoS One. 2014 Oct 31;9(10):e111459. doi: 10.1371/journal.pone.0111459. eCollection 2014.

7.

Association between preoperative plasma sRAGE levels and recovery from cardiac surgery.

Creagh-Brown BC, Quinlan GJ, Hector LR, Evans TW, Burke-Gaffney A.

Mediators Inflamm. 2013;2013:496031. doi: 10.1155/2013/496031. Epub 2013 Sep 5.

8.

Plasma thioredoxin levels during post-cardiac arrest syndrome: relationship with severity and outcome.

Mongardon N, Lemiale V, Borderie D, Burke-Gaffney A, Perbet S, Marin N, Charpentier J, Pène F, Chiche JD, Mira JP, Cariou A.

Crit Care. 2013 Jan 29;17(1):R18. doi: 10.1186/cc12492.

9.

Lest we forget the endothelial glycocalyx in sepsis.

Burke-Gaffney A, Evans TW.

Crit Care. 2012 Dec 12;16(2):121. doi: 10.1186/cc11239. Review.

10.

Differences in lipopolysaccharide- and lipoteichoic acid-induced cytokine/chemokine expression.

Finney SJ, Leaver SK, Evans TW, Burke-Gaffney A.

Intensive Care Med. 2012 Feb;38(2):324-32. doi: 10.1007/s00134-011-2444-5. Epub 2011 Dec 20.

11.

sRAGE: a useful biomarker in acute lung injury?

Creagh-Brown BC, Burke-Gaffney A, Evans TW.

Crit Care Med. 2011 Mar;39(3):589-90. doi: 10.1097/CCM.0b013e31820a8350. No abstract available.

PMID:
21330859
12.

The RAGE axis in systemic inflammation, acute lung injury and myocardial dysfunction: an important therapeutic target?

Creagh-Brown BC, Quinlan GJ, Evans TW, Burke-Gaffney A.

Intensive Care Med. 2010 Oct;36(10):1644-56. doi: 10.1007/s00134-010-1952-z. Epub 2010 Jul 15. Review.

PMID:
20631986
13.

Increased plasma thioredoxin levels in patients with sepsis: positive association with macrophage migration inhibitory factor.

Leaver SK, MacCallum NS, Pingle V, Hacking MB, Quinlan GJ, Evans TW, Burke-Gaffney A.

Intensive Care Med. 2010 Feb;36(2):336-41. doi: 10.1007/s00134-009-1640-z. Epub 2009 Sep 15. Review.

14.

Thioredoxin in sepsis: Just another biomarker or a plausible therapeutic target?

Burke-Gaffney A, Evans TW, Quinlan GJ.

Crit Care Med. 2009 Jul;37(7):2304-5. doi: 10.1097/CCM.0b013e3181a606dc. No abstract available.

PMID:
19535923
15.

PMX464, a thiol-reactive quinol and putative thioredoxin inhibitor, inhibits NF-kappaB-dependent proinflammatory activation of alveolar epithelial cells.

Callister ME, Pinhu L, Catley MC, Westwell AD, Newton R, Leaver SK, Quinlan GJ, Evans TW, Griffiths MJ, Burke-Gaffney A.

Br J Pharmacol. 2008 Nov;155(5):661-72. doi: 10.1038/bjp.2008.258. Epub 2008 Jun 30.

16.

Severe sepsis and Toll-like receptors.

Gao H, Leaver SK, Burke-Gaffney A, Finney SJ.

Semin Immunopathol. 2008 Feb;30(1):29-40. Epub 2007 Dec 11. Review.

PMID:
18071706
17.

Butanol-extracted lipoteichoic acid induces in vivo leukocyte adhesion.

Finney SJ, Anning PB, Cao TV, Perretti M, Evans TW, Burke-Gaffney A.

Biochem Biophys Res Commun. 2007 Dec 28;364(4):831-7. Epub 2007 Oct 24.

PMID:
17963694
18.

Sepsis since the discovery of Toll-like receptors: disease concepts and therapeutic opportunities.

Leaver SK, Finney SJ, Burke-Gaffney A, Evans TW.

Crit Care Med. 2007 May;35(5):1404-10. Review.

PMID:
17414083
19.

Persistently low plasma thioredoxin is associated with meningococcal septic shock in children.

Callister ME, Burke-Gaffney A, Quinlan GJ, Betts H, Nadel S, Evans TW.

Intensive Care Med. 2007 Feb;33(2):364-7. Epub 2006 Nov 18.

PMID:
17115131
20.

Extracellular thioredoxin levels are increased in patients with acute lung injury.

Callister ME, Burke-Gaffney A, Quinlan GJ, Nicholson AG, Florio R, Nakamura H, Yodoi J, Evans TW.

Thorax. 2006 Jun;61(6):521-7. Epub 2006 Apr 6.

21.

Thioredoxin: friend or foe in human disease?

Burke-Gaffney A, Callister ME, Nakamura H.

Trends Pharmacol Sci. 2005 Aug;26(8):398-404. Review. Erratum in: Trends Pharmacol Sci. 2006 Jan;27(1):9.

PMID:
15990177
22.

Regulation of chemokine expression in atherosclerosis.

Burke-Gaffney A, Brooks AV, Bogle RG.

Vascul Pharmacol. 2002 May;38(5):283-92. Review.

PMID:
12487033
23.
24.

Cytokine-activated human vascular smooth muscle delays apoptosis of neutrophils: relevance of interactions between cyclo-oxygenase-2 and colony-stimulating factors.

Stanford SJ, Pepper JR, Burke-Gaffney A, Mitchell JA.

FASEB J. 2001 Aug;15(10):1813-5. No abstract available.

PMID:
11481239
25.
26.

Cytokine-induced airway epithelial ICAM-1 upregulation: quantification by high-resolution scanning and transmission electron microscopy.

Zhu J, Rogers AV, Burke-Gaffney A, Hellewell PG, Jeffery PK.

Eur Respir J. 1999 Jun;13(6):1318-28.

27.

A CD18/ICAM-1-dependent pathway mediates eosinophil adhesion to human bronchial epithelial cells.

Burke-Gaffney A, Hellewell PG.

Am J Respir Cell Mol Biol. 1998 Sep;19(3):408-18.

PMID:
9730868
28.

Cyclo-oxygenase-2 regulates inducible ICAM-1 and VCAM-1 expression in human vascular smooth muscle cells.

Bishop-Bailey D, Burke-Gaffney A, Hellewell PG, Pepper JR, Mitchell JA.

Biochem Biophys Res Commun. 1998 Aug 10;249(1):44-7.

PMID:
9705828
30.

Interleukin-4 and lipopolysaccharide synergize to induce vascular cell adhesion molecule-1 expression in human lung microvascular endothelial cells.

Blease K, Seybold J, Adcock IM, Hellewell PG, Burke-Gaffney A.

Am J Respir Cell Mol Biol. 1998 May;18(5):620-30.

PMID:
9569232
31.

Endogenous nitric oxide limits cytokine-induced damage of murine lung epithelial cells.

Burke-Gaffney A, Hellewell PG.

Am J Physiol. 1997 Apr;272(4 Pt 1):L707-13.

PMID:
9142945
33.

Eotaxin stimulates eosinophil adhesion to human lung microvascular endothelial cells.

Burke-Gaffney A, Hellewell PG.

Biochem Biophys Res Commun. 1996 Oct 3;227(1):35-40.

PMID:
8858099
34.

Regulation of ICAM-1 by dexamethasone in a human vascular endothelial cell line EAhy926.

Burke-Gaffney A, Hellewell PG.

Am J Physiol. 1996 Feb;270(2 Pt 1):C552-61.

PMID:
8779919
36.

Does TNF-alpha directly increase endothelial cell monolayer permeability?

Burke-Gaffney A, Keenan AK.

Agents Actions. 1993;38 Spec No:C83-5.

PMID:
7686326

Supplemental Content

Loading ...
Support Center